Hypercholesterolemia Abrogates the Cardioprotection of Ischemic Postconditioning in Isolated Rat Heart: Roles of Glycogen Synthase Kinase-3β and the Mitochondrial Permeability Transition Pore
- 307 Downloads
- 10 Citations
Abstract
Ischemic postconditioning (IPO) reduces lethal reperfusion injury under normal conditions, but its effectiveness in hypercholesterolemia (HC) is disputed. We measured the cardioprotection of IPO in hypercholesterolemic rats and determined the roles of glycogen synthase kinase-3β (GSK-3β) and the mitochondrial permeability transition pore (mPTP). Isolated rat hearts underwent 30-min global ischemia and 120-min reperfusion. Postconditioning protocol induced six cycles of 10s ischemia and 10s reperfusion at the onset of the reperfusion. Myocardial infarct size was estimated by triphenyltetrazolium chloride staining and cardiomyocyte apoptosis was assessed by TUNEL staining. GSK-3β phosphorylation was measured by immunoblotting. The opening of mPTP was measured by NAD+ content in myocardium. In normocholesterolemia (NC) groups, infarct size and cardiomyocyte apoptosis were significantly reduced after IPO. These reductions were completely abolished by HC, as evidenced by a similar infarct size and cardiomyocyte apoptosis observed between the IPO-HC and IR (ischemia–reperfusion)-HC groups. GSK-3β phosphorylation was significantly higher in the IPO-NC than the IPO-HC group. In addition, NAD+ content in myocardium, a marker of mPTP opening, was higher in the IPO-NC group than the IPO-HC group. In conclusion, cardioprotection of IPO is blocked by hypercholesterolemia. This might be due to the impairment of phosphorylation of GSK-3β and attenuation of mPTP opening.
Keywords
Ischemic postconditioning Hypercholesterolemia Glycogen synthase kinase-3β Mitochondrial permeability transition poreNotes
Acknowledgments
These studies were supported by the Liaoning provincial science and technology projects, China (2009225051-1).
References
- 1.Zhao, Z. Q., Corvera, J. S., Haulkos, M. E., Kerendi, F., Wang, N. P., Guyton, R. A., et al. (2003). Inhibition of myocardial injury by ischemic postconditioning during reperfusion comparison with ischemic preconditioning. American Journal of Physiology, 285, 579–588.Google Scholar
- 2.Schwartz, L. M., & Lagranha, C. J. (2006). Ischemic postconditioning during reperfusion activates Akt and ERK without protecting against lethal myocardial ischemia-reperfusion injury in pigs. American Journal of Physiology, 290, 1011–1018.Google Scholar
- 3.Ferdinandy, P., Schulz, R., & Baxter, G. F. (2007). Interaction of cardiovascular risk factors with myocardial ischemia/reperfusion injury, preconditioning, and postconditioning. Pharmacological Reviews, 59, 418–458.PubMedCrossRefGoogle Scholar
- 4.Staat, P., Rioufol, G., Piot, C., Cottin, Y., Cung, T. T., L’Huillier, I., et al. (2005). Postconditioning the human heart. Circulation, 112, 2143–2148.PubMedCrossRefGoogle Scholar
- 5.Hansen, P. R., Thibault, H., & Abdulla, J. (2010). Postconditioning during primary percutaneous coronary intervention: A review and meta-analysis. The International Journal of Cardiology, 144, 22–25.CrossRefGoogle Scholar
- 6.Iliodromitis, E. K., Zoga, A., Vrettou, A., Andreadou, I., Paraskevaidis, I. A., Kaklamanis, I., et al. (2006). The effectiveness of postconditioning and preconditioning on infarct size in hypercholesterolemic and normal anesthetized rabbits. Atherosclerosis, 188, 356–362.PubMedCrossRefGoogle Scholar
- 7.Zhao, J. L., Yang, S. J., You, S. J., Cui, C. J., & Gao, R. L. (2007). Different effects of postconditioning on myocardial no-reflow in the normal and hypercholesterolemic mini-swines. Microvascular Research, 73, 137–142.PubMedCrossRefGoogle Scholar
- 8.Kupai, K., Csonka, C., Fekete, V., Odendaal, L., van Rooyen, J., de Marais, W., et al. (2009). Cholesterol diet-induced hyperlipidemia impairs the cardioprotective effect of postconditioning: role of peroxynitrite. American Journal of Physiology, 297, 1729–1735.Google Scholar
- 9.Lauzier, B., Delemasure, S., Pesant, M., Collin, B., Duvillard, L., Vergely, C., et al. (2009). A cholesterol-rich diet improves resistance to ischemic insult in mouse hearts but suppresses the beneficial effect of post-conditioning. American Journal of Physiology, 297, H1729–H1735.Google Scholar
- 10.Donato, M., D’Annunzio, V., Berg, G., Gonzalez, G., Schreier, L., Morales, C., et al. (2007). Ischemic postconditioning reduces infarct size by activation of A1 receptors and KATP channels in both normal and hypercholesterolemic rabbits. Journal of Cardiovascular Pharmacology, 49, 287–292.PubMedCrossRefGoogle Scholar
- 11.Zhao, H., Wang, Y., Wu, Y., Li, X., Yang, G., Ma, X., et al. (2009). Hyperlipidemia does not prevent the cardioprotection by postconditioning against myocardial ischemia/reperfusion injury and the involvement of hypoxia inducible factor-1a upregulation. Acta Biochimica et Biophysica Sinica (Shanghai), 41, 745–753.CrossRefGoogle Scholar
- 12.Gross, E. R., & Gross, G. J. (2006). Ligand triggers of classical preconditioning and postconditioning. Cardiovascular Research, 70, 212–221.PubMedCrossRefGoogle Scholar
- 13.Juhaszova, M., Zorov, D. B., Kim, S. H., Pepe, S., Fu, Q., Fishbein, K. W., et al. (2004). Glycogen synthase kinase-3beta mediates convergence of protection signaling to inhibit the mitochondrial permeability transition pore. The Journal of Clinical Investigation, 113, 1535–1549.PubMedCentralPubMedCrossRefGoogle Scholar
- 14.Nishihara, M., Miura, T., Miki, T., Tanno, M., Yano, T., Naitoh, K., et al. (2007). Modulation of the mitochondrial permeability transition pore complex in GSK-3beta-mediated myocardial protection. Journal of Molecular and Cellular Cardiology, 43, 564–570.PubMedCrossRefGoogle Scholar
- 15.Yadav, H. N., Singh, M., & Sharma, P. L. (2010). Modulation of the cardioprotective effect of ischemic preconditioning in hyperlipidaemic rat heart. European Journal of Pharmacology, 643, 78–83.PubMedCrossRefGoogle Scholar
- 16.Yadav, H. N., Singh, M., & Sharma, P. L. (2012). Pharmacological inhibition of GSK-3β produces late phase of cardioprotection in hyperlipidemic rat: possible involvement of HSP 72. Molecular and Cellular Biochemistry, 369, 227–233.PubMedCrossRefGoogle Scholar
- 17.Jia, D. (2011). The protective effect of mitochondrial ATP-sensitive K+ channel opener, Nicorandil, combined With Na+/Ca2+ exchange blocker KB-R7943 on myocardial ischemia–reperfusion injury in rat. Cell Biochemistry and Biophysics, 60, 219–224.PubMedCrossRefGoogle Scholar
- 18.Ren, Y., Cai, Y., & Jia, D. (2012). Comparative antiapoptotic effects of KB-R7943 and ischemic postconditioning during myocardial ischemia reperfusion. Cell Biochemistry and Biophysics, 64, 137–145.PubMedCrossRefGoogle Scholar
- 19.Di Lisa, F., & Ziegler, M. (2001). Pathophysiological relevance of mitochondria in NAD+ metabolism. FEBS Letters, 492, 4–8.PubMedCrossRefGoogle Scholar
- 20.Klingenberg, M. (1974). Spectrophotometric and fluorimetric methods. In H. U. Bergmeyer (Ed.), Methods of enzymatic analysis (2nd ed.). New York: Academic Press.Google Scholar
- 21.Ferdinandy, P., Szilvássy, Z., Horváth, L. I., Csont, T., Csonka, C., Nagy, E., et al. (1997). Loss of pacing-induced preconditioning in rat hearts: role of nitric oxide and cholesterol-enriched diet. The Journal of Molecular and Cellular Cardiology, 29, 3321–3333.CrossRefGoogle Scholar
- 22.Onody, A., Csonka, C., & Giricz, Z. (2003). Hyperlipidemia induced by a cholesterol-rich diet leads to enhanced peroxynitrite formation in rat hearts. Cardiovascular Research, 58, 663–670.PubMedCrossRefGoogle Scholar
- 23.Iliodromitis, E. K., Andreadou, I., Prokovas, E., Zoga, A., Farmakis, D., Fotopoulou, T., et al. (2010). Simvastatin in contrast to postconditioning reduces infarct size in hyperlipidemic rabbits: possible role of oxidative/nitrosative stress attenuation. Basic Research in Cardiology, 105, 193–203.PubMedCrossRefGoogle Scholar
- 24.Andreadou, I., Farmakis, D., Prokovas, E., Sigala, F., Zoga, A., Spyridaki, K., et al. (2012). Short-term statin administration in hypercholesterolemic rabbits resistant to postconditioning: effects on infarct size, endothelial nitric oxide synthase and nitro-oxidative stress. Cardiovascular Research, 94, 501–509.PubMedCrossRefGoogle Scholar
- 25.Crompton, M. (1999). The mitochondrial permeability transition pore and its role in cell death. The Biochemical Journal, 341, 233–249.PubMedCentralPubMedCrossRefGoogle Scholar
- 26.Gateau-Roesch, O., Argaud, L., & Ovize, M. (2006). Mitochondrial permeability transition pore and postconditioning. Cardiovascular Research, 70, 264–273.PubMedCrossRefGoogle Scholar
- 27.Griffiths, E. J., & Halestrap, A. P. (1993). Protection by cyclosporin A of ischemia reperfusion induced damage in isolated rat hearts. Journal of Molecular and Cellular Cardiology, 25, 1461–1469.PubMedCrossRefGoogle Scholar
- 28.Freixa, X., Bellera, N., Ortiz-Pérez, J. T., Jiménez, M., Paré, C., Bosch, X., et al. (2012). Ischaemic postconditioning revisited: lack of effects on infarct size following primary percutaneous coronary intervention. European Heart Journal, 33, 103–112.PubMedCrossRefGoogle Scholar
- 29.Tarantini, G., Favaretto, E., Marra, M. P., Frigo, A. C., Napodano, M., Cacciavillani, L., et al. (2012). Postconditioning during coronary angioplasty in acute myocardial infarction: the POST-AMI trial. The International Journal of Cardiology, 162, 33–38.CrossRefGoogle Scholar
- 30.Byrne, C. J., McCafferty, K., Kieswich, J., Harwood, S., Andrikopoulos, P., Raftery, M., et al. (2012). Ischemic conditioning protects the uremic heart in a rodent model of myocardial infarction. Circulation, 125, 1256–1265.PubMedCrossRefGoogle Scholar
- 31.Penna, C., Tullio, F., Moro, F., Folino, A., Merlino, A., & Pagliaro, P. (2010). Effects of a protocol of ischemic postconditioning and/or captopril in hearts of normotensive and hypertensive rats. Basic Research in Cardiology, 105, 181–192.PubMedCrossRefGoogle Scholar
- 32.Ren, J. Y., Song, J. X., Lu, M. Y., & Chen, H. (2011). Cardioprotection by ischemic postconditioning is lost in isolated perfused heart from diabetic rats: Involvement of transient receptor potential vanilloid 1, calcitonin gene-related peptide and substance P. Regulatory Peptides, 169, 49–57.PubMedCrossRefGoogle Scholar